Literature DB >> 24916186

Solid-phase library synthesis of bi-functional derivatives of oleanolic and maslinic acids and their cytotoxicity on three cancer cell lines.

Andres Parra1, Samuel Martin-Fonseca, Francisco Rivas, Fernando J Reyes-Zurita, Marta Medina-O'Donnell, Eva E Rufino-Palomares, Antonio Martinez, Andres Garcia-Granados, Jose A Lupiañez, Fernando Albericio.   

Abstract

A wide set of 264 compounds has been semisynthesized with high yields and purities. These compounds have been obtained through easy synthetic processes based on a solid-phase combinatorial methodology. All the members of this library have one central core of a natural pentacyclic triterpene (oleanolic or maslinic acid) and differ by 6 amino acids, coupled with the carboxyl group at C-28 of the triterpenoid skeleton, and by 10 different acyl groups attached to the hydroxyl groups of the A-ring of these molecules. According to the literature on the outstanding and promising pharmacological activities of other similar terpene derivatives, some of these compounds have been tested for their cytotoxic effects on the proliferation of three cancer cell lines: B16-F10, HT29, and Hep G2. In general, we have found that around 70% of the compounds tested show cytotoxicity in all three of the cell lines selected; around 60% of the cytotoxic compounds are more effective than their corresponding precursors, that is, oleanolic (OA) or maslinic (MA) acids; and nearly 50% of the cytotoxic derivatives have IC50 values between 2- to 320-fold lower than their corresponding precursor (OA or MA).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24916186     DOI: 10.1021/co500051z

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  6 in total

1.  Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity.

Authors:  Alberto M Parra-Perez; Amalia Pérez-Jiménez; Isabel Gris-Cárdenas; Gloria C Bonel-Pérez; Luis M Carrasco-Díaz; Khalida Mokhtari; Leticia García-Salguero; José A Lupiáñez; Eva E Rufino-Palomares
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

2.  Maslinic acid promotes autophagy by disrupting the interaction between Bcl2 and Beclin1 in rat pheochromocytoma PC12 cells.

Authors:  Xiaoli Dong; Jiaxiao Zhang; Zhilin Zhou; Zhennan Ye; Jiahao Chen; Jifan Yuan; Fengjun Cao; Xuanbin Wang; Wenchao Liu; Wenxuan Yu; Xiaohua Li
Journal:  Oncotarget       Date:  2017-08-05

3.  Antiproliferative and Pro-Apoptotic Effect of Uvaol in Human Hepatocarcinoma HepG2 Cells by Affecting G0/G1 Cell Cycle Arrest, ROS Production and AKT/PI3K Signaling Pathway.

Authors:  Gloria C Bonel-Pérez; Amalia Pérez-Jiménez; Isabel Gris-Cárdenas; Alberto M Parra-Pérez; José Antonio Lupiáñez; Fernando J Reyes-Zurita; Eva Siles; René Csuk; Juan Peragón; Eva E Rufino-Palomares
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

4.  Phytochemicals: "A Small Defensive Advantage for Plants and Fungi; a Great Remedy for the Health of Mankind".

Authors:  José A Lupiáñez; Eva E Rufino-Palomares
Journal:  Molecules       Date:  2021-10-12       Impact factor: 4.411

Review 5.  Nutraceutical Role of Polyphenols and Triterpenes Present in the Extracts of Fruits and Leaves of Olea europaea as Antioxidants, Anti-Infectives and Anticancer Agents on Healthy Growth.

Authors:  Eva E Rufino-Palomares; Amalia Pérez-Jiménez; Leticia García-Salguero; Khalida Mokhtari; Fernando J Reyes-Zurita; Juan Peragón-Sánchez; José A Lupiáñez
Journal:  Molecules       Date:  2022-04-05       Impact factor: 4.411

6.  Maslinic Acid, a Triterpene from Olive, Affects the Antioxidant and Mitochondrial Status of B16F10 Melanoma Cells Grown under Stressful Conditions.

Authors:  Khalida Mokhtari; Eva E Rufino-Palomares; Amalia Pérez-Jiménez; Fernando J Reyes-Zurita; Celeny Figuera; Leticia García-Salguero; Pedro P Medina; Juan Peragón; José A Lupiáñez
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-07       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.